Results 51 to 60 of about 8,262 (195)

Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan

open access: yesmSphere, 2016
The global spread of extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli (ESBL-E. coli) has largely been driven by the pandemic sequence type 131 (ST131).
Tohru Miyoshi-Akiyama   +9 more
doaj   +1 more source

Distribution of virulence determinants among Escherichia coli ST131 and its H30/H30-Rx subclones in Turkey

open access: yes, 2022
Extraintestinal pathogenic Escherichia coli (ExPEC) is the leading pathogen in urinary tract infection. In recent years multidrug-resistant B2-ST131 E. coli clonal group has disseminated worldwide.
Kadir, E. R. Doganhan   +5 more
core   +1 more source

Comparative Analysis of Uropathogenic Escherichia coli ST131 and Non-ST131 Isolated from Urinary Tract Infection Patients in Daejeon

open access: yesThe Korean Journal of Clinical Laboratory Science, 2020
Uropathogenic Escherichia coli (UPEC) is a major cause of urinary tract infections (UTIs), which is one of the most common infectious diseases in humans worldwide. Since UPEC is increasingly gaining resistance to many antimicrobial agents, antibiotic therapy of UTI has recently become a great concern.
openaire   +3 more sources

Genome and plasmid diversity of Extended-Spectrum β-Lactamase-producing Escherichia coli ST131 – tracking phylogenetic trajectories with Bayesian inference

open access: yesScientific Reports, 2019
Clonal lineages of ESBL (Extended-Spectrum β-Lactamase)-producing E. coli belonging to sequence type 131 (ST131) have disseminated globally during the last 30 years, leading to an increased prevalence of resistance to fluoroquinolones and extended ...
Sofia Ny   +3 more
doaj   +1 more source

Comparison of ST131 isolates.

open access: yes, 2019
Comparison of ST131 isolates.
Jana Jass (677208)   +5 more
core   +1 more source

Phenotypic microarrays suggest Escherichia coli ST131 is not a metabolically distinct lineage of extra-intestinal pathogenic E. coli. [PDF]

open access: yesPLoS ONE, 2014
Extraintestinal pathogenic E. coli (ExPEC) are the major aetiological agent of urinary tract infections (UTIs) in humans. The emergence of the CTX-M producing clone E. coli ST131 represents a major challenge to public health worldwide.
Abdulaziz Alqasim   +5 more
doaj   +1 more source

Novel genes associated with enhanced motility of Escherichia coli ST131

open access: yesPLOS ONE, 2017
Uropathogenic Escherichia coli (UPEC) is the cause of ~75% of all urinary tract infections (UTIs) and is increasingly associated with multidrug resistance. This includes UPEC strains from the recently emerged and globally disseminated sequence type 131 (ST131), which is now the dominant fluoroquinolone-resistant UPEC clone worldwide. Most ST131 strains
Asha Kakkanat   +4 more
openaire   +7 more sources

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2010
Escherichia coli sequence type 131 (ST131) is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. Its pandemic spread was identified in 2008 by utilizing multilocus sequence typing (MLST) of CTX-M-15 extended-spectrum β-lactamase-producing E. coli from three continents.
Rogers, BA, Sidjabat, HE, Paterson, DL
openaire   +5 more sources

Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region

open access: yesDiagnostics, 2022
Long-term care facilities (LTCFs) are important reservoirs of antimicrobial-resistant (AMR) bacteria which colonize patients transferred from the hospital, or they may emerge in the facility as a result of mutation or gene transfer. In the present study,
Sabrina Cherubini   +10 more
doaj   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy